Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Genetic test identifies dogs' risk of cruciate ligament damage
The findings enabled researchers to ascertain the genetic risk of developing cruciate ligament rupture in Labrador retrievers. 
The test only requires a cheek swab or blood sample. 

US researchers have developed a first-of-its-kind genetic test that identifies a dog's risk for cruciate ligament damage. 

The test, developed by scientists at the University of Wisconsin-Madison School of Veterinary Medicine, requires only a blood sample or a cheek swab that can be collected at home.

Researchers first developed the test for Labrador retrievers – a breed with a high risk of developing the disease – in September 2021. The team now hopes to extend the tool to other susceptible breeds, such as the Newfoundland and the Rottweiler.

Similar to the anterior cruciate ligament (ACL) in humans, the canine cranial cruciate ligament plays a crucial role in stabilising the knee joint in both species. While any dog can rupture the ligament, it seldom occurs through injury alone. 

Instead, the deterioration of the cruciate ligament, which increases the chance of rupture, is greatly influenced by genetics, scientists say.

Identifying if a dog is more likely to rupture a cruciate ligament due to genetics enables its owner and veterinary surgeon to take preventative action, such as keeping the dog healthy and monitoring for signs of injury. It can also help to avoid the recovery and expenses involved in a rupture. 

The new test was developed by Professor Peter Muir who, together with his team, analysed the genome of more than 1,000 Labrador retrievers across the USA. According to Muir, genetic markers for cruciate ligament ruptures are more complex than markers for other traits. 

Most genetic tests seek one particular DNA mutation to determine whether a particular disease or trait is present. However, several gene variants found across the dog's genome contribute to cruciate ligament rupture. 

“There are all these little variants that act together,” explained Muir, “so, any individual Labrador that inherits enough small effect variants in combination will have high genetic risk typical of a cruciate ligament rupture case.” 

The team used array genotyping to determine genetic markers for each dog. By studying the DNA and gene variants in multiple samples, they could pinpoint the minor variants associated with cruciate ligament rupture. 

Their findings enabled them to ascertain the genetic risk of developing cruciate ligament rupture in Labrador retrievers. They found a heritability estimate of 0.62, meaning for each Labrador that develops cruciate ligament rupture, about 62 per cent of the risk is genetic, and approximately 38 per cent is environmental. 

From this study, a cruciate ligament rupture genetic risk test for individual Labrador retrievers can now be performed in the lab with 98 per cent accuracy. Looking ahead, the team hopes to further genetic testing research for animals and humans alike.

“Our initial interest in the disease is as a spontaneous animal model for human orthopaedic disease,” Muir explains, to better understand human ACL tears and associated genetics.

Become a member or log in to add this story to your CPD history

NOAH board elected

News Story 1
 NOAH has elected its board team, as part of its annual general meeting.

Ned Flaxman, general manager at Norbrook Laboratories Ltd, retains his position as chair, which he has held since June 2023.

Caitrina Oakes (Vetoquinol) remains past chair, and Matthew Frost (Elanco) remains treasurer.

Andrew Buglass (Eco Animal Health Ltd), Oya Canbas (Zoetis) and Charlotte Covell (Virbac) are newly elected vice-chairs. Meanwhile Roy Geary (Ceva) and John Toole (Beaphar) join the NOAH Board of Management.

Dawn Howard, NOAH chief executive, said: "I congratulate all the officers and board members who have been elected or re-elected today.

"I look forward to working together to ensure that NOAH continues to deliver at the highest standard for its members." 

Click here for more...
News Shorts
Series two of SCOPS podcast launched

The Sustainable Control of Parasites in Sheep (SCOPS) Group has launched the second series of its podcast.

The series will comprise four episodes, with topics including the sustainable use of parasite treatments, effective quarantining, administrating a mid/late season dose, and tackling resistance to multiple groups of anthelmintic.

Kevin Harrison, Gloucestershire sheep farmer and SCOPS chair, said: "The podcast is suitable for sheep farmers, vets and advisers, so please subscribe and spread the word if you enjoy the content.

"All episodes from series one are still available online, as well as the new episodes being added."

The podcast is available on the SCOPS website and other podcast platforms.